PE Anti-mouse/human CD49d Antibody *PS/2*
PS/2 is an anti-mouse/human monoclonal antibody that forms an immune complex with the CD49d antigen. CD49d (sometimes called α4 integrin, Integrin α4 chain, VLA-4 α chain or Integrin alpha-4) is a 150 kD glycoprotein that is found on the surface of cells such as NK cells, dendritic cells and macrophages. CD49d is associated with a variety of biologically interesting macromolecules/ligands, for instance, Paxillin and CD106. CD49d is a fairly uncommon antibody target, with a little more than 3400 publications in the last decade. Even still, CD49d is vital to cell biology and immunology research, frequently serving as a phenotypic marker for differentiating cell types in flow cytometric applications. This antibody was purified through affinity chromatography and conjugated to PE (ex/em = 566/574 nm). It is compatible with the 561 nm laser and 586/20 nm bandpass filter (for example, as in the Agilent Technologies NovoCyte).
Spectrum
Conjugation
We provide custom conjugation services for this antibody (eg. labeling of cd49d antibody with HRP). A list of available labels can be found in the table below:
For additional information about custom conjugations, please consult our services page here.
AF | AF350, AF488, AF555, AF594, AF647, AF680, AF700, AF750 |
Proteins | HRP, Alkaline Phosphatase, Streptavidin |
Tandems | APC, APC/Cy7, APC/AF750, APC/iFluor™ 700, APC/iFluor™ 750, PE, PE/Cy5, PE/Cy7, PE/AF610, PE/AF700, PE/iFluor™ 594, PE/iFluor™ 647, PE/iFluor™ 700, PE/iFluor™ 750, PE/Texas Red®, PerCP, PerCP/Cy5.5 |
Small Molecules | Biotin |
Traditional Dyes | FITC (fluorescein), TRITC, PacBlue, PacOrange, Cy3, Cy5 |
iFluor | 350, 405, 430, 450, 488, 514, 532, 546, 555, 560, 568, 594, 610, 633, 647, 660, 670, 680, 700, 710, 750, 790, 800, 810, 820, 840, 860, A7 |
mFluor | UV375, UV460, Violet 450, Violet 500, Violet 510, Violet 540, Blue 570, Green 620, Red 700, Red 780 |
For additional information about custom conjugations, please consult our services page here.
Page updated on April 25, 2025